# Comparison of Dendritic Cells Versus Montanide as Adjuvants in a Melanoma Vaccine

> **NCT00124124** · PHASE1 · COMPLETED · sponsor: **Dr. Nina Bhardwaj** · enrollment: 50 (actual)

## Conditions studied

- Melanoma

## Interventions

- **DRUG:** KLH; Peptides; Dendritic Cells
- **DRUG:** KLH, peptides plus Montanide

## Key facts

- **NCT ID:** NCT00124124
- **Lead sponsor:** Dr. Nina Bhardwaj
- **Sponsor class:** INDIV
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-07
- **Primary completion:** 2008-07
- **Final completion:** 2009-04
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2015-02-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00124124

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00124124, "Comparison of Dendritic Cells Versus Montanide as Adjuvants in a Melanoma Vaccine". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT00124124. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*